Insider · CIK 0002065816
Mark Earl Hensley
cooofficer
Files at HRTX (HERON THERAPEUTICS, INC. /DE/). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Restricted Stock Unitsderivative | +188,315 | $0.00 | $0 | 188,315 | Feb 3, 2026 |
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Performance Stock Unitsderivative | +188,314 | $0.00 | $0 | 188,314 | Feb 3, 2026 |
| May 6, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Restricted Stock Unitsderivative | +500,000 | $0.00 | $0 | 500,000 | May 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.